Chu Lin

机构：Peking University, Peking University People's Hospital · ORCID：0000-0002-2365-9831

发表论文 80 篇 · 总被引 903 次 · h-index 16

代表论文

• Characterizing body composition modifying effects of a glucagon‐like peptide 1 receptor‐based agonist: A meta‐analysis (2024 · Diabetes Obesity and Metabolism · 被引 55)
• Anti-diabetic agents and the risks of dementia in patients with type 2 diabetes: a systematic review and network meta-analysis of observational studies and randomized controlled trials (2024 · Alzheimer s Research & Therapy · 被引 33)
• Effects of Semaglutide and Tirzepatide on Bone Metabolism in Type 2 Diabetic Mice (2024 · Pharmaceuticals · 被引 23)
• One or two? Comparison of the cardiorenal effects between combination therapy and monotherapy with SGLT2i or GLP1RA (2024 · Diabetes Obesity and Metabolism · 被引 13)
• Glucagon‐like peptide‐1 receptor agonist treatment associated weight fluctuation and influencing factors in patients with overweight or obesity (2025 · Diabetes Obesity and Metabolism · 被引 5)
• Metabolic syndrome in type 1 diabetes: higher time above range and glycemic variability revealed by continuous glucose monitoring (CGM) (2025 · Diabetology & Metabolic Syndrome · 被引 5)